These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26573220)

  • 1. Comparative efficacy of esomeprazole and omeprazole: Racemate to single enantiomer switch.
    Asghar W; Pittman E; Jamali F
    Daru; 2015 Nov; 23():50. PubMed ID: 26573220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of the effectiveness of esomeprazole in gastroesophageal reflux disease and Helicobacter pylori infection.
    Teng M; Khoo AL; Zhao YJ; Lin L; Lim BP; Wu TS; Dan YY
    J Clin Pharm Ther; 2015 Aug; 40(4):368-75. PubMed ID: 25893507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness and tolerability of esomeprazole and omeprazole in gastro-esophageal reflux disease: A systematic review and meta-analysis.
    Qi Q; Wang R; Liu L; Zhao F; Wang S
    Int J Clin Pharmacol Ther; 2015 Oct; 53(10):803-10. PubMed ID: 26329348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharma clinics medication of the month. Esomeprazole].
    Louis E
    Rev Med Liege; 2002 Sep; 57(9):610-2. PubMed ID: 12440351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.
    Röhss K; Lind T; Wilder-Smith C
    Eur J Clin Pharmacol; 2004 Oct; 60(8):531-9. PubMed ID: 15349707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single enantiomer versus racemate: chiral distinction in the proton pump inhibitors omeprazole and esomeprazole.
    Marom H; Pogodin S; Agranat I
    Chirality; 2014 Apr; 26(4):214-27. PubMed ID: 24619931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect comparison of randomised controlled trials: comparative efficacy of dexlansoprazole vs. esomeprazole in the treatment of gastro-oesophageal reflux disease.
    Wu MS; Tan SC; Xiong T
    Aliment Pharmacol Ther; 2013 Jul; 38(2):190-201. PubMed ID: 23718547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease.
    Lind T; Rydberg L; Kylebäck A; Jonsson A; Andersson T; Hasselgren G; Holmberg J; Röhss K
    Aliment Pharmacol Ther; 2000 Jul; 14(7):861-7. PubMed ID: 10886041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-isomer drugs: true therapeutic advances.
    Andersson T
    Clin Pharmacokinet; 2004; 43(5):279-85. PubMed ID: 15080761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.
    Miner P; Katz PO; Chen Y; Sostek M
    Am J Gastroenterol; 2003 Dec; 98(12):2616-20. PubMed ID: 14687806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esomeprazole magnesium (Nexium).
    Baker DE
    Rev Gastroenterol Disord; 2001; 1(1):32-41. PubMed ID: 12120118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of CYP2C19 genetic polymorphisms on the efficacy of proton pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis.
    Zhao F; Wang J; Yang Y; Wang X; Shi R; Xu Z; Huang Z; Zhang G
    Helicobacter; 2008 Dec; 13(6):532-41. PubMed ID: 19166419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esomeprazole: a clinical review.
    Johnson TJ; Hedge DD
    Am J Health Syst Pharm; 2002 Jul; 59(14):1333-9. PubMed ID: 12132559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esomeprazole: potent acid suppression in the treatment of acid-related disorders.
    Morgner-Miehlke A; Petersen K; Miehlke S; Labenz J
    Expert Rev Clin Immunol; 2005 Nov; 1(4):511-27. PubMed ID: 20477595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms.
    Katz PO; Koch FK; Ballard ED; Bagin RG; Gautille TC; Checani GC; Hogan DL; Pratha VS
    Aliment Pharmacol Ther; 2007 Jan; 25(2):197-205. PubMed ID: 17229243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.
    Richter JE; Kahrilas PJ; Johanson J; Maton P; Breiter JR; Hwang C; Marino V; Hamelin B; Levine JG;
    Am J Gastroenterol; 2001 Mar; 96(3):656-65. PubMed ID: 11280530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: pharmacology of esomeprazole and comparisons with omeprazole.
    Dent J
    Aliment Pharmacol Ther; 2003 Feb; 17 Suppl 1():5-9. PubMed ID: 12614299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving opportunities for effective management of gastro-oesophageal reflux disease.
    Vigneri S; Tonini M; Scarpignato C; Savarino V
    Dig Liver Dis; 2001 Nov; 33(8):720-30. PubMed ID: 11785720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroesophageal Acid Reflux Control 5 Years After Antireflux Surgery, Compared With Long-term Esomeprazole Therapy.
    Hatlebakk JG; Zerbib F; Bruley des Varannes S; Attwood SE; Ell C; Fiocca R; Galmiche JP; Eklund S; Långström G; Lind T; Lundell LR;
    Clin Gastroenterol Hepatol; 2016 May; 14(5):678-85.e3. PubMed ID: 26226096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis: comparison of esomeprazole and other proton pump inhibitors in eradicating Helicobacter pylori.
    Wang X; Fang JY; Lu R; Sun DF
    Digestion; 2006; 73(2-3):178-86. PubMed ID: 16837803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.